After a long hiatus, Lilly are now again dealing with a working peoples party in Britain, whose Health Secretary, Wes Streeting, is talking about getting everyone who is not working on weight loss drugs drugs to get them fighting fit and able to get back to work Embracing Healthcare Opportunities
A1C reduction at 40 weeks: Weight loss at 40 weeks (T2D patients): Tirzepatide produced more weight loss and stronger A1C reduction at every dose level tested
While not everyone experiences them, if the side effects become bothersome or intolerable, it may prompt individuals to discuss other treatment options with their healthcare provider
The STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that people taking semaglutide 2.4 mg weekly lost an average of 15-22% of baseline body weight over 68 weeksapproximately 35-50 pounds for someone starting at 250 pounds
Hone clinicians see that daily injections tend to be harder to stick with, which often matters more for results than the drugs theoretical potency